Correlation Between Cue Biopharma and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Anebulo Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Anebulo Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cue and Anebulo is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Anebulo Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to generate 2.41 times more return on investment than Anebulo Pharmaceuticals. However, Cue Biopharma is 2.41 times more volatile than Anebulo Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 139.00 in Cue Biopharma on November 4, 2024 and sell it today you would earn a total of 6.00 from holding Cue Biopharma or generate 4.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| Anebulo Pharmaceuticals |
Cue Biopharma and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Anebulo Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |